Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportMolecular Targeting Probes - Radioactive & Nonradioactive

Zr-89 labeling of mesoporic silica based nanoparticles

Benjamin Baur, Larissa Miller, Elena Andreolli, Hans Machulla, Sven Reske, Mika Lindén and Christoph Solbach
Journal of Nuclear Medicine May 2014, 55 (supplement 1) 1231;
Benjamin Baur
1Clinic for Nuclear Medicine, University Ulm, Ulm, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Larissa Miller
2Department of Inorganic Chemistry, University Ulm, Ulm, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Elena Andreolli
3Department of Health Sciences, University of Milano-Bicocca, Milan, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hans Machulla
1Clinic for Nuclear Medicine, University Ulm, Ulm, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sven Reske
1Clinic for Nuclear Medicine, University Ulm, Ulm, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mika Lindén
2Department of Inorganic Chemistry, University Ulm, Ulm, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christoph Solbach
1Clinic for Nuclear Medicine, University Ulm, Ulm, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Abstract

1231

Objectives Mesoporic silica based nanoparticels (MSN) provide versatile perspectives as drug delivery vehicles. In contrast to nonporous silica nanoparticels the MSN have a tremendous increased surface, which can be functionalized and conjugated to multiple residues for targeting and for chelation of radionuclides. This may lead to a clearly improved signal to noise ratio in PET. Also, for a therapeutic application multiple labeling would be of highest interest. Due to slow in vivo accumulation radionuclides with long half-life and sufficient positron percentage are preferred for the PET application. Zr-89 with a half-life of 78,4 h is a well suited positron emitting radionuclide for this purpose. Our goal was the development of a convenient radiolabeling procedure for MSN with Zr-89 for later in vivo experiments.

Methods MSN (size: 200 nm, surface:275 m2/g) were functionalized with propylamino groups which were conjugated in the next step with desferrioxamine. Radiosynthesis of 89Zr-DFO-MSN was developed regarding reaction-time and amount of MSN. Labeling reactions were carried out at room temperature in a MSN suspension (10-100 µg) in 0,1 M NH4OAc buffer of pH 7.7. RCY were determined after 1, 5, 15 and 30 min reaction time. Stability was monitored for 24 h.

Results The functionalization of the MSN was verified by elementary analysis and adsorption measurements. For low concentrations of 10 µg the RCY obtained after 5 min was 67% and increased to a RCY >99% after 15 min. Using higher concentration of the MSN starting from 50 µg a quantitative RCY was obtained after just 1 min. 89Zr-DFO-MSN showed stability over 24h.

Conclusions An efficient method for the labeling of MSN with high surface as a new agent for PET imaging was developed. Quantitative labeling yield were observed already after a reaction time of 15 minutes. Moreover, the ability to label desferal conjugated MSN under mild conditions (room temperature, pH = 7,7) avoids decomposition of the MSN.

Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 55, Issue supplement 1
May 2014
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Zr-89 labeling of mesoporic silica based nanoparticles
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Zr-89 labeling of mesoporic silica based nanoparticles
Benjamin Baur, Larissa Miller, Elena Andreolli, Hans Machulla, Sven Reske, Mika Lindén, Christoph Solbach
Journal of Nuclear Medicine May 2014, 55 (supplement 1) 1231;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Zr-89 labeling of mesoporic silica based nanoparticles
Benjamin Baur, Larissa Miller, Elena Andreolli, Hans Machulla, Sven Reske, Mika Lindén, Christoph Solbach
Journal of Nuclear Medicine May 2014, 55 (supplement 1) 1231;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Molecular Targeting Probes - Radioactive & Nonradioactive

  • Relationships between tau, atrophy, regional brain activity and connectivity in Alzheimer's disease: a PET/MRI multimodal study
  • Gray matter structural networks related to 18F-THK5351 retention in cognitively normal older adults and early Alzheimer’s disease patients
  • Assessment of α4β2 nicotinic acetylcholine receptor (nAChR) availability and neuronal response to rewarding food-cues in human obesity using simultaneous PET-MRI
Show more Molecular Targeting Probes - Radioactive & Nonradioactive

Special MTA: Cardiovascular, Endocrine, Other Posters

  • In vivo labeling of serum albumin for positron emission tomography
  • Development of 111In-labeled Exendin-4 derivative for the imaging of glucagon-like peptide-1 receptor expression in pancreatic islets
Show more Special MTA: Cardiovascular, Endocrine, Other Posters

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire